glp 1 agonist anesthesia GLP-1 medications safe to continue before surgery in patients with diabetes and obesity Study: Most Patients Can Safely

48.Monti G., Gomes Moreira D., Richner M., Mutsaers H

Is tirzepatide better than Semaglutide GLP-1 for obesity

Mechanisms underlying the anorexigenic effects of dual GIPR/GLP-1R agonists GIPR/GLP-1R dual agonists induce significantly greater weight loss than GLP-1RAs alone in both animal models and human [29, 30]

Review article: Endpoints used in functional dyspepsia drug therapy trials

In 2019, about 21,000 people in the U.S

The consistency of findings across multiple retrospective cohorts and data sources provides a compelling signal of efficacy on clinical endpoints, justifying a shift in research focus: the field now needs adequately powered phase 3 randomized controlled trials to validate these preliminary findings [58], define optimal treatment strategies such as dosing and treatment duration, and establish the role of GLP-1 RAs in both acute and long-term management of IIH